Log In
Print
BCIQ
Print
Print this Print this
 

ALB 109564(a)

  Manage Alerts
Collapse Summary General Information
Company Albany Molecular Research Inc.
DescriptionSemi-synthetic analog of marketed tubulin inhibitors
Molecular Target Tubulin
Mechanism of ActionTubulin inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today